dc.contributor.author |
M. N. Tillyashayhov, N. E. Atahanova, D. M. Almuradova, N. I. Tursunova and L. T. Gaziev. |
|
dc.date.accessioned |
2022-10-12T13:59:33Z |
|
dc.date.available |
2022-10-12T13:59:33Z |
|
dc.date.issued |
2022 |
|
dc.identifier.issn |
2455-3301 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/3797 |
|
dc.description.abstract |
This article analyzes the main clinical, morphological and molecular biological factors that influence the outcome of the disease, and their proportion is determined. Favorable prognosis factors include: lack of lymphovascular invasion, tumor infiltration by lymphocytes, lack of expression of PD-1 / PD-L1, mTOR, VEGF-A and KIT, low proliferation index. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Other |
en_US |
dc.subject |
Renal cell cancer, immunohistochemistry, prognosis, tumor receptors. |
en_US |
dc.title |
Renal cell cancer prognostic factors |
en_US |
dc.type |
Article |
en_US |